Pipeline of Tinnitus Reviewed for H2 2015 in New Market Research Report

PUNE, India, October 28, 2015 /PRNewswire/ --

LifeScienceIndustryResearch.com adds "Tinnitus - Pipeline Review, H2 2015" market research report that provides an overview of the Tinnitus's therapeutics pipeline, to the pharmaceuticals collection of its online library.

This report provides comprehensive information on the therapeutic development for Tinnitus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tinnitus and special features on late-stage and discontinued projects. Complete report spread across 68 pages, discussing 9 companies and relevant drug profiles is available at http://www.lifescienceindustryresearch.com/tinnitus-pipeline-review-h2-2015.html .

The report also reviews key players involved in the therapeutic development for Tinnitus and special features on late-stage and discontinued projects. Companies discussed in this Tinnitus - Pipeline Review, H2 2015 report include AudioCure Pharma GmbH, Auris Medical Holding AG, Flexion Therapeutics, Inc., Knopp Biosciences LLC, Merz Pharma GmbH & Co. KgaA, Otonomy, Inc., SciFluor Life Sciences, LLC, Sound Pharmaceuticals, Inc. and Synphora AB.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are acamprosate calcium, AM-102, AUT-00063, AUT-3, Drug to Activate KCNQ for Tinnitus, esketamine hydrochloride, gacyclidine SR, latanoprost, neramexane mesylate, SF-0034, Small Molecules for Tinnitus, Small Molecules to Activate Kv7 for Neuropathic Pain, Epilepsy and Tinnitus, Small Molecules To Inhibit TNF-Alpha for Tinnitus, SPI-1005 and SPI-3005. Order a copy of this report @ http://www.lifescienceindustryresearch.com/purchase?rname=63088 .

Featured News & Press Releases covered by this report include: Jul 02, 2015: Auris Medical Holding Provides Update on U.S. Intellectual Property Portfolio. Jun 19, 2015: SciFluor Life Sciences Patented Compound SF0034 Highlighted in Research Published in The Journal of Neuroscience. Apr 20, 2015: Auris Medical Announces Publications Related to AM-101 in Peer-Reviewed Scientific and Medical Journals. Mar 13, 2015: Auris Medical Announces Recently Granted Patent in India for the Treatment of Tinnitus. Mar 11, 2015: Auris Medical to Host Key Opinion Leader Meeting on Tinnitus Treatments on March 13 in New York City. Mar 10, 2015: Auris Medical Announces Completion of Interim Analysis in Post-Acute Tinnitus Stratum of TACTT3 Trial with AM-101. Feb 11, 2015: Auris Medical Announces Recently Granted Patent in China for the Treatment of Tinnitus. Jan 14, 2015: Auris Medical Holding AG Achieves 50% Enrolment Milestone in Post-Acute Tinnitus Stratum of TACTT3 Clinical Trial. Jun 04, 2014: Autifony Therapeutics awarded £2.2 million to progress first-in-classdrug for tinnitus into Phase IIa study. Mar 31, 2014: Published Analysis Confirms Positive Results from Auris Medical's Phase IIb Study with AM-101 in Treatment of Acute Inner Ear Tinnitus.

List of Tables provided in this tinnitus pipeline review report include: 

Number of Products under Development for Tinnitus, H2 2015 8

Number of Products under Development for Tinnitus - Comparative Analysis, H2 2015 9

Number of Products under Development by Companies, H2 2015 10

Number of Products under Investigation by Universities/Institutes, H2 2015 11

Comparative Analysis by Late Stage Development, H2 2015 12

Comparative Analysis by Clinical Stage Development, H2 2015 13

Comparative Analysis by Early Stage Development, H2 2015 14

Comparative Analysis by Unknown Stage Development, H2 2015 15

Products under Development by Companies, H2 2015 16

Products under Investigation by Universities/Institutes, H2 2015 17

Assessment by Monotherapy Products, H2 2015 27

Number of Products by Stage and Target, H2 2015 29

Number of Products by Stage and Mechanism of Action, H2 2015 31

Number of Products by Stage and Route of Administration, H2 2015 33

Number of Products by Stage and Molecule Type, H2 2015 34

Tinnitus Therapeutics - Recent Pipeline Updates, H2 2015 54

Tinnitus - Dormant Projects, H2 2015 60

Explore more reports on Pharmaceuticals industry at http://www.lifescienceindustryresearch.com/category/pharmaceuticals .

About Us:   

LifeScienceIndustryResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@lifescienceindustryresearch.com